Can You “Do it Better”? Applying New Strategies into Obesity Care
Released On
May 19, 2023
Expires On
May 19, 2024
Media Type
Internet
Completion Time
60 minutes
Specialty
Primary Care Physicians, Nurse Practitioners, Physician Associates/Physician Assistants
Topic(s)
Incretins, GLP-1 RAs, GIP/GLP-1 RA Coagonist, Tirzepatide, Obesity, Pharmacotherapy, Bariatric Surgery
Scroll to the Bottom of this Information to Begin this Course
This activity is provided by Clinical Care Options, LLC in partnership with RealCME.
This activity is supported by an educational grant from Lilly.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
- Nurses — 1.0 ANCC Contact Hour
- Physician Assistant - 1.0 AAPA Category 1 Credit
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
The primary target audience for this education is primary care physicians. The secondary target audience is primary care nurse practitioners and physician associates/physician assistants.
Program Overview
The goal of this program is to improve primary care provider knowledge and competence (application of knowledge) and demonstrate improvement in clinical performance to optimize treatment for patients with obesity.
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Assess patients according to the guideline criteria for diagnosis and pharmacologic management of obesity
- Develop strategies to overcome biases and barriers associated with the chronic management of obesity
- Integrate shared decision-making techniques into patient interactions on obesity management
- Incorporate guideline recommendations, the latest clinical evidence, and patient-specific factors to select antiobesity medications for long-term management among appropriate patients
- Apply strategies to improve the likelihood of long-term weight loss based on an assessment of treatment response, patient preferences, and adherence
Faculty
Robert Kushner, MD, MS
Professor
Departments of Medicine and Medical Education
Northwestern University Feinberg School of Medicine
Director
Center for Lifestyle Medicine
Northwestern Medicine
Chicago, Illinoisy
Christopher D. Still, DO, FACN, FACP
Professor of Medicine
Department of Clinical Sciences
Geisinger Commonwealth School of Medicine
Medical Director
Center for Nutrition and Weight Management
Director
Geisinger Center for Obesity and Metabolic Research
Geisinger Health System
Danville, Pennsylvania
Accreditation Information
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.
Physician Assistant/Physician Associate Continuing Medical Education
Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. Approval is valid until 5/18/24. PAs should only claim commensurate with the extent of their participation.
Program Medium
This program has been made available online.
Disclosures of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Faculty
The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity.
- Robert Kushner, MD, MS
- Consultant/Advisor/Speaker: Epitomee, Lilly, Novo Nordisk, Pfizer, WW
- Christopher D. Still, DO, FACN, FACP
- Consultant/Advisor/Speaker: Novo Nordisk; researcher: Ethicon Endo-Surgery
Staff
The planners and content peer reviewers from Clinical Care Options, LLC and RealCME do not have any relevant financial relationships to disclose, except Amy Butts, PA-C, as noted below.
- Amy Butts, PA-C
- Consultant: ABayer, Novo Nordisk, Provention Bio, Xeris
Instructions for Participation and Credit
Participation in this self-study activity should be completed in approximately 1.0 hour. To successfully complete this activity and receive credit, learners must follow these steps during the period from 5/18/23, through 5/18/24
- Read the target audience, learning objectives, and faculty disclosures.
- View and study the content in its entirety.
- Submit answers to the post-test questions and evaluation questions online.
You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. You will be able to claim your credit and certificate immediately after completing the activity. There are no costs/fees for this activity.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by healthcare professionals without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Contact Information
To contact Postgraduate Institute for Medicine (PIM) please visit www.pimed.com. For technical issues, please contact info@dkbmed.com.